Celldex Therapeutics IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 38.485 USD | 40,3 USD | 19,72 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 55,467 USD | 12 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 78.492.072 | 11,59 | 5,8 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Celldex Therapeutics Inc
Mitarbeiter 198
Handelsplatz NASDAQ
Ticker Symbol CLDX
IPO Datum 2008-03-10
Adresse Perryville III Building, Hampton, NJ, United States, 08827
Webseite https://www.celldex.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director |
| 2 | Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP |
| 3 | Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP |
| 4 | Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs |
| 5 | Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| 6 | Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration |
| 7 | Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel |
| 8 | Dr. Ronald A. Pepin Ph.D. | Chief Business Officer & Senior VP |
| 9 | Dr. Diane C. Young M.D. | Senior VP & Chief Medical Officer |
| 10 | Ms. Teri L. Lawver | SVP & Chief Commercial Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 2 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 6 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 9 | COMMODORE CAPITAL LP | 0,00% | 0,00 Mio. USD |
| 10 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 11 | Eversept Partners, LP | 0,00% | 0,00 Mio. USD |
| 12 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | BRAIDWELL LP | 0,00% | 0,00 Mio. USD |
| 14 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 15 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 17 | Novo A/S | 0,00% | 0,00 Mio. USD |
| 18 | Bellevue Group AG | 0,00% | 0,00 Mio. USD |
| 19 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 20 | Eventide Asset Management, LLC | 0,00% | 0,00 Mio. USD |